Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

about

Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

Item

http://www.wikidata.org/entity/Q57495769

description

scientific article published on 25 July 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

@en

Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

@nl

type

Item

label

Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

@en

Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

@nl

prefLabel

Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

@en

Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

@nl

P1476

Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

@en

P2093

Carmen Reyero-Fernández

http://www.w3.org/2001/XMLSchema#string

Lourdes Carrillo-Guivernau

http://www.w3.org/2001/XMLSchema#string

P2860

Localization techniques for guided surgical excision of non-palpable breast lesions

Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial

Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.

Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).

Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer.

P304

238-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000491760

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Octavi Cordoba

P577

2018-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30319325

http://www.w3.org/2001/XMLSchema#string

P932

6167713

http://www.w3.org/2001/XMLSchema#string